Hypothesis: Increased cell motility is a hallmark of cancer cells. Proteins
involved in cell motility may be used as molecular markers to characterize
the malignant potential of tumors. Methods: Molecular biology and immunohi
stochemistry techniques were used to investigate the expression of a select
ed panel of motility-related proteins (Rho A, Pac 2, Cdc42, PI(3)K, 2E4, an
d Arp2) in normal, premalignant, and squamous cell cancer cell lines of hum
an head and neck origin. To assess the clinical potential of these proteins
as molecular markers for cancer, immunohistochemistry was performed on par
affin-fixed head and neck cancer specimens (n = 15). Results: All six motil
ity-associated proteins were overexpressed in the premalignant and squamous
cell cancer cell Lines relative to normal keratinocytes. Immunohistochemis
try with Rho A and Pac 2 showed increased staining in areas of cancer but n
ot in normal tissue. Conclusion: Proteins involved in cell motility can be
used as markers for head and neck squamous cell carcinoma. The head and nec
k cell lines used in this study may be used as a model to further investiga
te cell motility. Molecular markers of motility could have a significant im
pact on the diagnosis and staging of cancers originating from differentiate
d non-motile cells.